MindImmune Therapeutics
Kingston, US · Founded 2016 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MindImmune Therapeutics was founded in 2016 by Robert B. Nelson, Frank S. Menniti, and Stevin Zorn.
RB
Robert B. NelsonCo-founder
FS
Frank S. MennitiCo-founder
SZ
Stevin ZornCo-founder
IS
Isaac StonerCEO
Board
RG
Richard G. HoranBoard director
RB
Reetika BhardwajBoard director
CO
Christopher O'DonnellBoard director
BM
Bradley MargusBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$21.3M disclosed across 3 rounds · 2019–2025
▶$15.2MraisedMar 2026 · 15 investors · PharmaceuticalsRule 506(b)
▶$15.2MraisedMar 2026 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Reetika BhardwajDirector
- Christopher O'DonnellDirector
- Bradley MargusDirector
- Isaac StonerExecutive Officer, Director
- Offering amount
- $17M
- Amount sold
- $15.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.3MraisedFeb 2022 · 12 investors · PharmaceuticalsRule 506(b)
▶$5.3MraisedFeb 2022 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert B. NelsonExecutive Officer
- Christopher O'DonnellDirector
- Tracy SaxtonDirector
- Stevin ZornExecutive Officer, Director
- Diane GoodingExecutive Officer
- Offering amount
- $8.9M
- Amount sold
- $5.3M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedNov 2019 · 8 investors · PharmaceuticalsRule 506(b)
▶$750KraisedNov 2019 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert B. NelsonExecutive Officer, Director
- Frank S. MennitiExecutive Officer, Director
- Richard G. HoranDirector
- Stevin ZornExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $750K
- Proceeds to insiders
- $875K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded MindImmune Therapeutics?
- MindImmune Therapeutics was founded by Robert B. Nelson, Frank S. Menniti, Stevin Zorn in 2016.
- Who are MindImmune Therapeutics's investors?
- MindImmune Therapeutics's investors include Pfizer Venture Investments.
- How much funding has MindImmune Therapeutics raised?
- MindImmune Therapeutics has disclosed $21.3M raised across 3 rounds.
- Where is MindImmune Therapeutics headquartered?
- MindImmune Therapeutics is headquartered in Kingston, US.